Chongbiao Huang

5PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 27, 2026
Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Tianxing Zhou, Jingrui Yan, Guohua Mao

|Dec 05, 2025
Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer.

Chao Wu, Weishuai Liu, Xiangting Hu

|Nov 14, 2025
Tumor-Derived Interleukin 35 Promotes Fibrosis in the Tumor Microenvironment of Pancreatic Cancer by Activating Pancreatic Stellate Cells.

Hui Li, Huizhi Sun, Jing Liu

|Jun 19, 2024
BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism.

Huizhi Sun, Hui Li, Yuqi Guan

|Jan 19, 2024
Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma.

Huizhi Sun, Yi Ge, Jing Liu

Pageof 1

Frequent Collaborators

4 joint publications

Antao Chang

4 joint publications

Jihui Hao

2 joint publications

Huizhi Sun

2 joint publications

Peiqing Sun